Chair, Ferronova
| Role | Organisation | Sources |
|---|---|---|
| Chair | Ferronova | SmartCompany, Startup Daily |
| Chair (former) | FerronovaPrecision cancer treatment technology | ferronova.com.au |
Stories naming Dr John Parker. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Adelaide biotech Ferronova raised $11 million for its cancer-detection nanotechnology, with Renew Pharmaceuticals and a government CRC contributing, following an earlier $4.6 million Series A in 2020.
Also SmartCompany
Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.
Also SmartCompany·SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily
Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.